Search is Powered by Google
Cancer / Oncology News

Body's Own Stem Cells Could Trigger Cancer Spread

rate icon Editor's Choice
Main Category: Cancer / Oncology
Also Included In: Stem Cell Research;  Breast Cancer
Article Date: 04 Oct 2007 - 0:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:4 stars

4 (9 votes)

Health Professional:5 stars

5 (3 votes)

Article Opinions: 1 posts

Your body's own stem cells could trigger alterations in cancer cells which facilitate their spreading around the body, say scientist from the Whitehead Institute, USA. They found that human breast cancer in mice have a higher chance of spreading if they are blended with bone marrow stem cells. Fortunately, say the scientists, it is perhaps feasible to reverse the process, undermining the deadliness of the cancer.

You can read about this study in the journal Nature.

When metastasis occurs it is much harder to treat the cancer. Metastasis is when the cancer invades other parts of the body and forms new tumors. In this study, the scientists intended to find out whether it was possible to stop this from happening - they wanted to find a means of isolating the cancer to one part of the body; stopping it from metastasizing (spreading, invading other parts).

The researchers have found an association with a specific type of stem cell, which encourages the breast cancer cells to spread to other parts of the body. They are found in the bone marrow, and are called Mesenchymal stem cells. These stem cells generally turn into cartilage, bone fat and muscle.

Previous studies had indicated that these stem cells generally migrated in huge numbers to where tumors were situated, meaning they were probably involved in the spread of the cancer. The researchers mixed these stem cells with human breast cancer cells in mice and found they spread to the lungs at seven times their normal rate.

The scientists believe the stem cells alter the cancer cells so that they metastasize. However, they add that as soon as they had spread, those cancer cells returned to their original genetic make-up. The bad news here is that as they revert back to their original genetic make up they are hard to identify, the good news, say the researchers, is that it is most likely they can find a way of blocking the whole process.

"Mesenchymal stem cells within tumour stroma promote breast cancer metastasis"
Antoine E. Karnoub, Ajeeta B. Dash, Annie P. Vo, Andrew Sullivan, Mary W. Brooks, George W. Bell, Andrea L. Richardson, Kornelia Polyak, Ross Tubo & Robert A. Weinberg.
Nature 449, 557-563; doi:10.1038/nature06188.
Click here to view abstract online

Written by: Christian Nordqvist
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Understanding And Treating Triple-Negative Breast Cancer
07 Jan 2009
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...